Research and Markets (http://www.researchandmarkets.com/research/kkp9j6/analysis_of_the) has announced the addition of the "Analysis of the US Retinal Therapeutics Market" report to their offering.

Since the introduction of Lucentis in 2006, vascular endothelial growth factor (VEGF) antagonists have become the clear choice in treatment for age related macular degeneration, diabetic macular edema, and retinal vein occlusion due to their high efficacy and safety.

This research service evaluates the US market for the pharmaceutical management of AMD, DME, and RVO from 2009 to 2017, with 2012 as the base year. Segmentation by disorder is provided. Included are products on the market, products in development, and patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed.

Key Questions Answered

- Is the market growing, how long will it continue to grow, and at what rate?

- Are the existing competitors structured correctly to meet customer needs?

- What pipeline candidates have the greatest potential? When are they expected to reach market?

- Which treatments are set to dominate the market? How much market share for each competitor?

- What is the peak sales potential for AMD, DME, and RVO market?

- What the strengths and weaknesses of current and future therapies?

Key Topics Covered:

1. Executive Summary

2. Market Overview

3. Competitive Playbook

4. Total Retinal Therapeutics Market

- Drivers and Restraints

- Forecasts and Trends

5. Competitive Environment

6. AMD Segment Breakdown

7. DME Segment Breakdown

8. RVO Segment Breakdown

9. Key Companies to Watch

10. The Last Word

Appendix

For more information visit http://www.researchandmarkets.com/research/kkp9j6/analysis_of_the

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals